PHARMACOLOGICAL SUPERVISION: THE EUROPEAN EXPERIENCE

Authors: Gratsianskaya A.N.¹, Gratsianskaya AN²
Affiliations:
1. Российский государственный медицинский университет им. Н.И. Пирогова (ГОУ ВПО РГМУРосздрава)
2. THE Russian State Medical University
Issue: Vol 8, No 3 (2011)
Pages: 65-67
Section: Articles
URL: https://ogarev-online.ru/raj/article/view/121236
DOI: https://doi.org/10.36691/RJA806
ID: 121236

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

medicines, drug safety, pharmacological supervision

Российский государственный медицинский университет им. Н.И. Пирогова (ГОУ ВПО РГМУРосздрава)

Email: lusslv@yandex.ru
Российский государственный медицинский университет им. Н.И. Пирогова (ГОУ ВПО РГМУРосздрава)

THE Russian State Medical University

WHO Policy Perspectives on Medicines - Pharmacovigilance: ensuring the safe use of medicines http://whqlibdoc.who. int/hq/2004/WHO_EDM_2004.8.pdf.
http://teratology.org.
http://www.who.int.
Shakir SA.W. PEM in the UK. In: Mann R.D., Andrews E., editors. Pharmacovigilance. Chichester, UK: John Wiley & Sons Ltd. 2002.
Volume IX of the rules governing Medicinal Products for Human and Veterinary Use in the EU. Version December 2001 [online]. Available from URL: http://www.pharmacos.eudra.org/.
Mosley J.N.S. Risk Management. A European Regulatory Perspective. Drug Safety. 2004, v. 27 (8), p. 499-508.

Supplementary Files

Action

1. JATS XML